A study conducted at the Hebrew University of Jerusalem shows that cannabidiol, a non-psychoactive component of cannabis, can slow the progression of Alzheimer’s disease in the brain.
“The research, still at an early stage, indicates that memory loss, the first and primary symptom of Alzheimer’s disease, can be slowed down significantly in mice by cannabidiol. Alzheimer’s disease, the most common form of dementia, affects some 24.3 million people worldwide.”
In the study, mice were injected with a molecule to induce symptoms of Alzheimers and treated with cannabidiol. Following treatment, learning was assessed by measuring the length of time needed to complete a maze.
“Those mice injected with cannabidiol successfully performed the task within 25-30 seconds, compared to mice in the control group who had not been treated with cannabidiol, who took almost double the amount of time, 45-50 seconds, to complete the task.”
Did you know cannabinoids are known to act as neuroprotective agents in the brain? Read the study, published in the Journal of Neuroscience, and titled “Prevention of Alzheimer’s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation”